• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Pharmaceutical Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 18 (2019)
Volume Volume 17 (2018)
Issue Special Issue 2
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Special Issue 1
Issue Issue 1
Volume Volume 16 (2017)
Volume Volume 15 (2016)
Volume Volume 14 (2015)
Volume Volume 13 (2014)
Volume Volume 12 (2013)
Volume Volume 11 (2012)
Volume Volume 10 (2011)
Volume Volume 9 (2010)
Volume Volume 8 (2009)
Volume Volume 7 (2008)
Volume Volume 6 (2007)
Volume Volume 5 (2006)
Volume Volume 4 (2005)
Volume Volume 3 (2004)
Volume Volume 2 (2003)
Volume Volume 1 (2002)
Bahmanof, H., Dadashzadeh, S., Zarghi, A., Shafaati, A., Foroutan, M. (2018). Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH101; a New Synthesized COX2 Inhibitor after I.V. and Oral Administration in Male and Female Rats. Iranian Journal of Pharmaceutical Research, 17(1), 115-123. doi: 10.22037/ijpr.2018.2154
Hoda Bahmanof; Simin Dadashzadeh; Afshin Zarghi; Alireza Shafaati; Mohsen Foroutan. "Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH101; a New Synthesized COX2 Inhibitor after I.V. and Oral Administration in Male and Female Rats". Iranian Journal of Pharmaceutical Research, 17, 1, 2018, 115-123. doi: 10.22037/ijpr.2018.2154
Bahmanof, H., Dadashzadeh, S., Zarghi, A., Shafaati, A., Foroutan, M. (2018). 'Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH101; a New Synthesized COX2 Inhibitor after I.V. and Oral Administration in Male and Female Rats', Iranian Journal of Pharmaceutical Research, 17(1), pp. 115-123. doi: 10.22037/ijpr.2018.2154
Bahmanof, H., Dadashzadeh, S., Zarghi, A., Shafaati, A., Foroutan, M. Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH101; a New Synthesized COX2 Inhibitor after I.V. and Oral Administration in Male and Female Rats. Iranian Journal of Pharmaceutical Research, 2018; 17(1): 115-123. doi: 10.22037/ijpr.2018.2154

Physicochemical, Stress Degradation Evaluation and Pharmacokinetic Study of AZGH101; a New Synthesized COX2 Inhibitor after I.V. and Oral Administration in Male and Female Rats

Article 11, Volume 17, Issue 1, Winter 2018, Page 115-123  XML PDF (722.08 K)
Document Type: Research article
DOI: 10.22037/ijpr.2018.2154
Authors
Hoda Bahmanof1; Simin Dadashzadeh2; Afshin Zarghi3; Alireza Shafaati3; Mohsen Foroutan email 4
1Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Sciences
2Department of Pharmaceutics, School of Pharmacy, Shahid Beheshti University of Medical Science
3Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences
4School of Pharmacy, Shahid Beheshti University of Medical Sciences
Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) act mainly via inhibition of prostaglandins synthesis by inhibition of cyclooxygenase (COX) isoenzymes (COX1 and COX 2). Selective COX-2 inhibitors which are also known as coxibs provide the main therapeutic effects of NSAIDs. Zarghi et al. reported 6-benzoyl-2-(4-(methylsulfonyl)phenyl)quinoline-4-carboxylic acid (AZGH 101) as a novel derivative of ketoprofen with improved selectivity index (COX-1/COX-2 inhibitory potency) in comparison with ketoprofen.
In this study the log P and stability of AZGH 101 was evaluated and the pharmacokinetic characteristics of this compound were investigated following intravenous (10 mg/kg), and oral administration (20 mg/kg), to Wistar rats.
As the data demonstrated the AZGH 101 classified as lipid soluble compound and had suitable stability according to forced degradation protocol ICH guideline for new drug substance. This derivative absorbs, distributes and eliminates similar in both sexes. The AUC 0-∞, absolute bioavailability, Cl and Vd were not different in both sexes.
According to the obtained data the AZGH 101 has not a sex dependent pharmacokinetic in Wistar rats.
Keywords
pharmacokinetic; Ketoprofen; selective COX-2 inhibitors; AZGH 101; Wistar rat
Main Subjects
Pharmacutics
Statistics
Article View: 717
PDF Download: 3,082
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Statistics

Journal Management System. Designed by sinaweb.